Post-earnings recap
Reported
Mon, Aug 4, 2025
EPS actual
$1.29
EPS est.
$1.31
EPS surprise
-1.53%
1-day move
-14.04%
Est. EPS
—
Est. Rev
—
Impl. Move
—
This earnings report indicates that Krystal Biotech faced challenges in meeting earnings expectations, resulting in a significant stock drop of 14.04%. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. Management's defensive tone suggests they are aware of the hurdles ahead but are focusing on their ongoing projects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.29 | N/A | -1.53% |
| Revenue | N/A | N/A | N/A |
Management expressed caution regarding future expectations. They highlighted ongoing projects but did not provide specific guidance.
Management did not provide specific guidance for future performance.
The company is focusing on its core projects despite the current challenges.